Exact Sciences Officer Plans $375K Stock Sale Under 10b5-1 Plan
EXACT SCIENCES CORP
Subscribe to track EXAS
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Exact Sciences Officer Plans $375K Stock Sale
Company: EXACT SCIENCES CORP (EXAS) Form: 144 | Filed: 2025-11-19 Significance: Low
Insider: ORVILLE JACOB A Title: Officer | Relationship: Officer
Transaction: • Type: Proposed Sale • Shares: 5,000 • Price: ~$75.00 • Value: $375,000 • Owned After: Not Disclosed
Key Insight: An officer filed an intent to sell a small number of shares, representing a negligible fraction of the company's market cap. The sale is pre-scheduled under a 10b5-1 plan, indicating it is likely for personal financial planning rather than a reaction to company events.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: EXACT SCIENCES CORP (EXAS)
Executive Summary
- Trading Significance: Low
- Key Takeaway: An officer at Exact Sciences has filed a notice of a proposed sale of 5,000 shares valued at $375,000. The transaction is pre-scheduled under a Rule 10b5-1 plan, adopted in May 2025.
- Market Impact: The sale is of low significance, representing a negligible percentage of the company's market capitalization and shares outstanding, and is unlikely to impact the stock price.
Company Information
| Field | Value |
|---|---|
| Company | EXACT SCIENCES CORP |
| Ticker Symbol | EXAS |
| CIK | 0001124140 |
| Industry | SERVICES-MEDICAL LABORATORIES |
Insider Information
| Field | Value |
|---|---|
| Name | ORVILLE JACOB A |
| CIK | 0001263312 |
| Title/Position | Officer |
| Relationship | Officer |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 144 |
| Transaction Date | 2025-11-19 (Approximate) |
| Transaction Code | S (Proposed Sale) |
| Security Type | Common Stock |
| Shares Involved | 5,000 |
| Price Per Share | $75.00 |
| Total Value | $375,000 |
| Shares Owned After | Not Disclosed |
| Ownership Type | Not Disclosed |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $375,000 |
| % of Market Cap | 0.00295% |
| Shares Transacted | 5,000 |
| % of Shares Outstanding | 0.00264% |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: For a company with a market capitalization of $12.70 billion, this $375,000 transaction is financially immaterial.
- Transaction Significance: The sale represents less than 0.003% of both the market cap and the total shares outstanding, falling far below the thresholds for moderate or high significance.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The transaction size is too small to influence market sentiment. The presence of a 10b5-1 plan further neutralizes the signal, as the sale was pre-arranged.
Volume & Sentiment
- Expected Volume Impact: Negligible. The transaction size is a tiny fraction of typical daily trading volume.
- Sentiment Indicator: Neutral. This is a routine insider transaction for liquidity or diversification purposes.
Additional Context
Transaction Notes
- Special Circumstances: The filing indicates this proposed sale is pursuant to a Rule 10b5-1 trading plan adopted on May 27, 2025. This allows insiders to sell shares at predetermined times to avoid accusations of trading on non-public information.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.